grant

Molecular targeting to telomerase and cancer cell immortality by a novel inhibitor [ 2008 - 2010 ]

Also known as: Telomerase inhibitor

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/519501]

Researchers: Dr He Li (Principal investigator) ,  Prof Jun-Ping Liu

Brief description Infinite growth of cancer cells is a hallmark of cancer. Telomerase is required for cancer cell immortality. Inhibition of telomerase may thus offer an opportunity to stop cancer cells. We have identified an inhibitor of telomerase. This project will study the mechanisms of action of the novel inhibitor, investigating how to control cancer cell immortality as a baseline for more applied anti-cancer therapeutic studies.

Funding Amount $AUD 430,812.94

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857